Kelly Financial Services LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Kelly Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jul 17, 2024	SELL	$7.0 - $16.87 $595 - $1,433	-85 Closed	0 $0
Q3 2021 Jul 17, 2024	SELL	$98.85 - $138.91 $807,307 - $1.13 Million	-8,167 Reduced 98.97%	85 $11.8 Million
Q2 2021 Jul 17, 2024	BUY	$65.78 - $105.02 $537,225 - $857,698	8,167 Added 9608.24%	8,252 $85,000
Q2 2020 Jul 17, 2024	SELL	$29.01 - $74.23 $12,039 - $30,805	-415 Reduced 83.0%	85 $6.21 Million
Q1 2020 Jul 17, 2024	BUY	$27.51 - $57.29 $13,755 - $28,645	500 New	500 $17 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.